Cargando…
Itraconazole therapy for infant hemangioma: Two case reports
BACKGROUND: Infantile hemangiomas (IHs) are the most common childhood benign tumors, showing distinctive progression characteristics and outcomes. Due to the high demand for aesthetics among parents of IH babies, early intervention is critical in some cases. β-Adrenergic blockers and corticosteroids...
Autores principales: | Liu, Zhe, Lv, Sha, Wang, Shuang, Qu, Sheng-Ming, Zhang, Gui-Yun, Lin, Yi-Tong, Yang, Lei, Li, Fu-Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554448/ https://www.ncbi.nlm.nih.gov/pubmed/34754871 http://dx.doi.org/10.12998/wjcc.v9.i28.8579 |
Ejemplares similares
-
Itraconazole Oral Solution for a Case of Infantile Hemangioma: Monitoring the Efficacy by Dermoscopy and MRI
por: Huang, Ying, et al.
Publicado: (2021) -
UPLC-MS/MS Measurement of the Effect of Isavuconazole, Itraconazole and Fluconazole on the Pharmacokinetics of Selinexor in Rats
por: Li, Shuang-long, et al.
Publicado: (2020) -
Itraconazole inhibits proliferation, induces apoptosis, and reduces angiogenesis of hemangioma endothelial cells by downregulating the hedgehog signaling pathway
por: Dong, Jianyong, et al.
Publicado: (2023) -
Propranolol intervention therapy for infants with facial hemangioma
por: Meng, Jian, et al.
Publicado: (2012) -
Oral propranolol therapy in 23 infants with infantile hemangioma
por: Kim, Jaeyoon, et al.
Publicado: (2018)